Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 312.50 | 120.45 | 593.00 | 495.75 | 1.1962 | 1.1834 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 312.50 | 120.45 | 124.00 | 495.75 | 0.2501 | 0.0143 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 312.50 | 120.45 | 505.00 | 495.75 | 1.0187 | 1.0182 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 596.00 | 495.75 | 1.2022 | 1.1889 | |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 312.50 | 120.45 | 348.00 | 495.75 | 0.7020 | 0.6817 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 312.50 | 120.45 | 169.00 | 495.75 | 0.3409 | 0.1805 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 550.00 | 495.75 | 1.1094 | 1.1044 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 312.50 | 120.45 | 487.00 | 495.75 | 0.9824 | 0.9826 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 457.00 | 495.75 | 0.9218 | 0.9218 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 408.00 | 495.75 | 0.8230 | 0.8180 | |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 476.00 | 495.75 | 0.9602 | 0.9606 | |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 312.50 | 120.45 | 480.00 | 495.75 | 0.9682 | 0.9686 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 312.50 | 120.45 | 503.00 | 495.75 | 1.0146 | 1.0143 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 312.50 | 120.45 | 693.00 | 495.75 | 1.3979 | 1.3567 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 664.00 | 495.75 | 1.3394 | 1.3078 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 312.50 | 120.45 | 566.00 | 495.75 | 1.1417 | 1.1342 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 312.50 | 120.45 | 640.00 | 495.75 | 1.2910 | 1.2666 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 312.50 | 120.45 | 522.00 | 495.75 | 1.0530 | 1.0512 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 312.50 | 120.45 | 538.00 | 495.75 | 1.0852 | 1.0818 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 312.50 | 120.45 | 769.00 | 495.75 | 1.5512 | 1.4799 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 674.00 | 495.75 | 1.3596 | 1.3248 | |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 312.50 | 120.45 | 790.00 | 495.75 | 1.5935 | 1.5129 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 312.50 | 120.45 | 558.00 | 495.75 | 1.1256 | 1.1193 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 312.50 | 120.45 | 691.00 | 495.75 | 1.3938 | 1.3533 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 312.50 | 120.45 | 476.00 | 495.75 | 0.9602 | 0.9606 |